Drägerwerk AG & Co. KGaA / Key word(s): Transaction in Own Shares 10.03.2015 18:01 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Ad hoc report in accordance with Sec. 15 of the German Securities Trading Act (Wertpapierhandelsgesetz - WpHG) Drägerwerk AG & Co. KGaA: Share buyback for the employee participation program The Executive Board of Drägerwerk Verwaltungs AG, as general partner of Drägerwerk AG & Co. KGaA ("Dräger"), resolved to acquire up to 237,600 of its own preferred shares in order to implement the employee participation program. The actual number of preferred shares that are to be purchased depends on the level of employee participation. For every three Dräger preferred shares (investment shares) employees purchase, they will be given an additional Dräger preferred share as a bonus share. A total of roughly 6,600 employees are eligible to participate. The number of investment shares is restricted to 27 preferred shares per employee. All preferred shares acquired within the scope of the program are subject to a holding period of two years. In the last employee participation program in 2013, 18.6 percent of eligible employees took part, acquiring an average of 17.8 investment shares. If the level of participation is the same in 2015, Dräger will acquire roughly 29,135 preferred shares for the employee participation program on the capital market. The share buyback principally complies with rules and regulations set forth in Sec. 71 (1) Sentence 1 No. 2 AktG (Aktiengesetz â German Stock Corporation Act). The buyback of preferred shares intended for persons not employed by the Company or any associated company, neither at the present time nor in the past, will take place in accordance with the authorization issued by the Company's annual shareholders' meeting dated May 4, 2012, which permits the buyback of up to 10 percent of capital stock held in the form of own shares. In both cases, the buyback complies with the so-called safe-harbor rules set forth in Secs. 14 (2) and 20a (3) WpHG in conjunction with Commission Regulation (EC) No. 2273/2003 implementing Directive 2003/6/EC of the European Parliament and of the Council as regards exemptions for buy-back programs and stabilization of financial instruments. The buyback will take place on the stock exchange. The purchase price will be in accordance with the requirements set forth in the safe-harbor rules. In addition, the purchase price per preferred share (excluding acquisition charges) of those preferred shares to be acquired on the basis of the authorization issued by the annual shareholders' meeting may not exceed or fall below the price of the preferred shares in the opening auction in XETRA trading on the Frankfurt Stock Exchange on the trading day in question by more than 10 percent. The buyback will be performed by the mandated bank within a period of two weeks from March 12, 2015. Dräger may extend the buyback period if necessary. The bank alone will decide on the specific time of purchase of the preferred shares. Dräger will report on the course of the buyback program in accordance with the legal provisions on the Company's website (www.draeger.com) in the Investor Relations section. [March 10, 2015] Drägerwerk AG & Co. KGaA Moislinger Allee 53-55 23558 Lübeck, Germany www.draeger.com 10.03.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Drägerwerk AG & Co. KGaA Moislinger Allee 53-55 23542 Lübeck Germany Phone: +49 (0)451 882-0 Fax: +49 (0)451 882-2080 E-mail: info@draeger.com Internet: www.draeger.com ISIN: DE0005550602, DE 000 555 063 6, DE 000 555 065 1, DE 000 555 067 7, DE 000 555 071 9 WKN: 555060, 555063 Vorzüge, 555065 Genussschein A, 555067 Genussschein K, 555071 Genussschein D Indices: TecDAX Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich; Regulated Unofficial Market in Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Share buyback for
Top 10 Most Recent News Articles
LAFC Turns Empty Seats Into an AI Test Case for Sports
Empty seats are a lousy kind of inventory A vacant stadium seat is perishable inventory with the clock screaming at it. LAFC and AccelerAI have aimed their first co-developed AI project at that unglamorous but important problem: getting more ticket holders through the gate without simply hacking prices down at the last minute. That is a far more sensible use of artificial...
Continue Reading
Paratus on the Move: Seagems JV Under the Microscope
What's Cooking with Paratus Energy? Paratus Energy Services Ltd. (ticker: PLSV) just threw us a curveball, announcing a strategic review of its participation in the Seagems joint venture. Now, before you get too jazzed about ticker talk—hold your horses. No one's making any promises about transactions just yet. The decision's still hanging in the balance, even as they...
Continue Reading
Iberostar's Grand Move: Opening in Zanzibar
The Resort That Takes Your Breath Away Here we have Iberostar, boldly wading into the azure waters of the Indian Ocean, planting its flag on the sandy beaches of Zanzibar. This isn’t just another notch on the resort’s belt—it’s their first time setting up shop in East Africa, a move ripe with promise and adventure both. A Suite So Sweet 358 suites, mind you. Each...
Continue Reading
Auria, LSAS Team Up: Japan Space Frontier Beckons
Pioneering Ventures in Japan's Space Race Watch out, folks—Auria and LSAS Tec have something cooking. One's a titan in space technology, and the other's a maestro in mission analysis. They're joining forces to tango in Japan's booming space market. If you're into the street-smart equity dance, this partnership ain't just chatter over coffee; it's a leap toward new...
Continue Reading
Docusign Pushes Contract Data Into ChatGPT Sales Tools
Contracts are where sales momentum goes to get lost, buried under old PDFs, approval chains, and somebody’s half-finished CRM note. Docusign’s November 17, 2026 launch is a sensible attempt to drag that information into the place sellers may increasingly spend their working day: ChatGPT for Sales. The company’s new plugin lets a sales rep pull agreement intelligence...
Continue Reading
AI Echo Study Sharpens a Difficult HFpEF Diagnosis
A single echo clip may be doing more useful work than plenty of flashy healthcare AI demos. The November 2026 Journal of Cardiac Failure focus issue puts a hard number on that possibility: pairing an AI read of a routine echocardiogram clip with the H?FPEF clinical score identified 78% of patients with hemodynamically confirmed HFpEF, versus 48% with the score alone. That...
Continue Reading
Snowhawk Enters Telarus as Digital Demand Gets Serious
Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...
Continue Reading
Elisity’s Texas Water Pilot Puts IonQ’s Deal in View
Water-system security is not a place for chest-thumping Elisity’s role in Texas Project Watershed 250 lands on a problem that is painfully concrete: water and wastewater utilities have to keep pumps, treatment systems and plant operations running while trying to close cybersecurity gaps. That is a tougher job than selling another dashboard to a corporate IT department....
Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks
Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...
Continue Reading
Animal Parasite Market Growth Has a Resistance Catch
Flea collars and cattle worms do not sound glamorous, yet this is exactly where durable animal-health revenue gets built. Wissen Research puts the global animal parasiticides market at $13.6 billion in 2026 and projects $18.6 billion by 2031, a 6.5% compound annual growth rate. That is respectable, not moonshot stuff, and frankly that is part of the appeal. Pet owners...
Continue ReadingTop 5 Most Recently Viewed Articles
Orion180 Unveils Innovative Customizable Flood Insurance
Orion180 Launches Customizable Residential Flood Insurance Orion180 is making waves in the insurance sector by introducing its latest offering: a Residential Private Flood Insurance product designed to meet a variety of homeowner needs. Based in Melbourne, this innovative insurance leader is set to change how we approach flood insurance with a product that emphasizes...
Continue Reading
DIFD AUTO Revolutionizes Global Car Buying with Crypto Payments
Transforming the Car Buying Experience with Cryptocurrency Today, as the digital landscape continues to evolve, DIFD AUTO stands at the forefront of a revolutionary shift in how consumers purchase vehicles. As a leading platform for cryptocurrency-based car transactions, DIFD AUTO allows customers around the globe to purchase brand-new, certified cars using major...
Continue Reading
Curtiss-Wright Reports Impressive Q3 Results and Outlook Boost
Curtiss-Wright's Positive Financial Performance Curtiss-Wright Corporation (NYSE: CW) is a well-known global company recognized for providing highly engineered products and services. Recently, the company reported noteworthy financial results for the third quarter. The sales surged nearly 10% year-over-year, coming close to $800 million, with exceptional growth especially...
Continue Reading
Darling Ingredients Reports Q3 2024 Results Amid Challenges
Third Quarter 2024 Overview Darling Ingredients Inc. today reported net income of $16.9 million, or $0.11 per diluted share for the third quarter of 2024. This represents a significant decline compared to net income of $125.0 million, or $0.77 per diluted share, in the third quarter of 2023. The notable decrease in net income is attributed to lower fat prices and reduced...
Continue Reading
Investigation Launched for Investors of Spyre Therapeutics, Inc.
Investigation Launched into Spyre Therapeutics, Inc. Pomerantz LLP has announced an investigation on behalf of investors of Spyre Therapeutics, Inc., known by its stock ticker, NASDAQ: SYRE. This inquiry stems from allegations that the company, along with some of its executives and board members, may have been involved in securities fraud or engaged in other unlawful...
Continue Reading